Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Foster City, California
- Most recent report
- 8-K, filed Oct 13, 2026
- Incorporated
- Delaware
- Filings on record
- 668 filings
- On EDGAR
- CIK 1759425
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 29
News 8 of 86
Prospectuses and Registrations 8 of 28
- S-3ASR Automatic shelf registration Feb 25, 2026
- S-8 Registration statement for an employee plan Feb 25, 2026
- S-8 Registration statement for an employee plan Sep 9, 2025
- S-3ASR Automatic shelf registration Aug 12, 2025
- S-8 Registration statement for an employee plan Feb 26, 2025
- S-8 Registration statement for an employee plan Mar 15, 2024
- S-8 Registration statement for an employee plan Nov 2, 2023
- 424B5 Prospectus supplement for an offering Nov 2, 2023
Proxies 8 of 14
- DEFA14A Extra proxy material Apr 23, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2026
- DEFA14A Extra proxy material Apr 14, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 14, 2025
- DEFA14A Extra proxy material Apr 23, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2024
- DEFA14A Extra proxy material May 1, 2023
- DEF 14A Proxy statement for a shareholder vote May 1, 2023
Ownership 8 of 475
- 4 Insider reported a trade Oct 19, 2026
- 4 Insider reported a trade Oct 14, 2026
- 4 Insider reported a trade Oct 6, 2026
- 3 Insider reported their initial holding Sep 22, 2026
- 144 Notice of a proposed sale of restricted stock Sep 15, 2026
- 4 Insider reported a trade Sep 15, 2026
- 4 Insider reported a trade Sep 3, 2026
- 4 Insider reported a trade Sep 3, 2026
Other 8 of 36
- ARS Annual report sent to shareholders Apr 24, 2026
- D Jan 29, 2026
- ARS Annual report sent to shareholders Apr 14, 2025
- ARS Annual report sent to shareholders Apr 23, 2024
- NT 10-K Notice that an annual report will be late Feb 28, 2024
- ARS Annual report sent to shareholders May 1, 2023
- EFFECT Notice that a registration became effective Jun 9, 2022
- CORRESP Reply to SEC staff Jun 6, 2022
Everything here comes from Mirum Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.